Boehringer Ingelheim partners with Sino Biopharmaceutical
Boehringer Ingelheim partners with Sino Biopharmaceutical in a $7.4 billion cancer drug development deal.
Boehringer Ingelheim partners with Sino Biopharmaceutical in a $7.4 billion cancer drug development deal.
Picky eating affects 25%-66% of toddlers, and pediatric experts explain why it peaks between 18 months and two…
From November 4 to 6, 2026, SEHA Al Dhafra Hospitals will convene its fifth annual Health Forum at…
Malaysian children as young as 14 are now facing type 2 diabetes due to rising obesity, warns Health…
Diabetes damages kidneys via high blood sugar, raising chronic kidney disease risk. Up to 40% of people with…
Boehringer Ingelheim partners with Sino Biopharmaceutical in a $7.4 billion cancer drug development deal.